OMNICELL INC (OMCL) Stock Fundamental Analysis
USA - NASDAQ:OMCL - US68213N1090 - Common Stock
31.055 USD
+0.05 (+0.18%)
We assign a fundamental rating of 4 out of 10 to OMCL. OMCL was compared to 190 industry peers in the Health Care Equipment & Supplies industry. OMCL has an average financial health and profitability rating. OMCL has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year OMCL was profitable.
In the past year OMCL had a positive cash flow from operations.
Of the past 5 years OMCL 4 years were profitable.
Each year in the past 5 years OMCL had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 1.08%, OMCL is in the better half of the industry, outperforming 73.68% of the companies in the same industry.
The Return On Equity of OMCL (1.83%) is better than 75.26% of its industry peers.
OMCL's Return On Invested Capital of 0.89% is fine compared to the rest of the industry. OMCL outperforms 67.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.08% | ||
| ROE | 1.83% | ||
| ROIC | 0.89% |
ROA(3y)-0.02%
ROA(5y)1.07%
ROE(3y)-0.07%
ROE(5y)1.98%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
OMCL has a better Profit Margin (2.01%) than 73.68% of its industry peers.
OMCL's Profit Margin has declined in the last couple of years.
OMCL has a better Operating Margin (1.52%) than 66.32% of its industry peers.
In the last couple of years the Operating Margin of OMCL has declined.
With a Gross Margin value of 43.88%, OMCL is not doing good in the industry: 63.16% of the companies in the same industry are doing better.
OMCL's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.52% | ||
| PM (TTM) | 2.01% | ||
| GM | 43.88% |
OM growth 3Y-60.62%
OM growth 5Y-43.72%
PM growth 3Y-45.27%
PM growth 5Y-30.27%
GM growth 3Y-4.46%
GM growth 5Y-2.57%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), OMCL is destroying value.
The number of shares outstanding for OMCL has been increased compared to 1 year ago.
The number of shares outstanding for OMCL has been increased compared to 5 years ago.
OMCL has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 1.92 indicates that OMCL is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 1.92, OMCL is doing good in the industry, outperforming 60.53% of the companies in the same industry.
OMCL has a debt to FCF ratio of 3.83. This is a good value and a sign of high solvency as OMCL would need 3.83 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.83, OMCL belongs to the top of the industry, outperforming 84.21% of the companies in the same industry.
OMCL has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
OMCL has a Debt to Equity ratio of 0.13. This is comparable to the rest of the industry: OMCL outperforms 58.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 3.83 | ||
| Altman-Z | 1.92 |
ROIC/WACC0.13
WACC6.73%
2.3 Liquidity
OMCL has a Current Ratio of 1.42. This is a normal value and indicates that OMCL is financially healthy and should not expect problems in meeting its short term obligations.
OMCL has a worse Current ratio (1.42) than 76.84% of its industry peers.
OMCL has a Quick Ratio of 1.24. This is a normal value and indicates that OMCL is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.24, OMCL is doing worse than 67.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.42 | ||
| Quick Ratio | 1.24 |
3. Growth
3.1 Past
OMCL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.50%, which is quite impressive.
The Earnings Per Share has been decreasing by -9.56% on average over the past years.
Looking at the last year, OMCL shows a small growth in Revenue. The Revenue has grown by 6.39% in the last year.
The Revenue has been growing slightly by 4.40% on average over the past years.
EPS 1Y (TTM)25.5%
EPS 3Y-23.52%
EPS 5Y-9.56%
EPS Q2Q%-11.76%
Revenue 1Y (TTM)6.39%
Revenue growth 3Y-0.59%
Revenue growth 5Y4.4%
Sales Q2Q%4.98%
3.2 Future
OMCL is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.56% yearly.
OMCL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.77% yearly.
EPS Next Y-7%
EPS Next 2Y0.31%
EPS Next 3Y6.56%
EPS Next 5YN/A
Revenue Next Year4.08%
Revenue Next 2Y3.92%
Revenue Next 3Y4.12%
Revenue Next 5Y3.77%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 16.61 indicates a correct valuation of OMCL.
OMCL's Price/Earnings ratio is rather cheap when compared to the industry. OMCL is cheaper than 84.74% of the companies in the same industry.
When comparing the Price/Earnings ratio of OMCL to the average of the S&P500 Index (27.41), we can say OMCL is valued slightly cheaper.
With a Price/Forward Earnings ratio of 18.15, OMCL is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of OMCL indicates a rather cheap valuation: OMCL is cheaper than 81.05% of the companies listed in the same industry.
OMCL's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.87.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.61 | ||
| Fwd PE | 18.15 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of OMCL indicates a rather cheap valuation: OMCL is cheaper than 84.21% of the companies listed in the same industry.
OMCL's Price/Free Cash Flow ratio is rather cheap when compared to the industry. OMCL is cheaper than 90.53% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.99 | ||
| EV/EBITDA | 12.56 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.31%
EPS Next 3Y6.56%
5. Dividend
5.1 Amount
OMCL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:OMCL (9/24/2025, 9:48:53 AM)
31.055
+0.05 (+0.18%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners103.41%
Inst Owner Change3.35%
Ins Owners1.78%
Ins Owner Change1.86%
Market Cap1.43B
Analysts77.14
Price Target44.88 (44.52%)
Short Float %4.3%
Short Ratio3.61
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)46.47%
Min EPS beat(2)24.34%
Max EPS beat(2)68.6%
EPS beat(4)4
Avg EPS beat(4)32.49%
Min EPS beat(4)1.42%
Max EPS beat(4)68.6%
EPS beat(8)8
Avg EPS beat(8)81.06%
EPS beat(12)12
Avg EPS beat(12)121.92%
EPS beat(16)14
Avg EPS beat(16)93.28%
Revenue beat(2)2
Avg Revenue beat(2)2.64%
Min Revenue beat(2)1.68%
Max Revenue beat(2)3.59%
Revenue beat(4)3
Avg Revenue beat(4)1.11%
Min Revenue beat(4)-1.27%
Max Revenue beat(4)3.59%
Revenue beat(8)5
Avg Revenue beat(8)1.39%
Revenue beat(12)8
Avg Revenue beat(12)1.02%
Revenue beat(16)9
Avg Revenue beat(16)0.47%
PT rev (1m)-0.75%
PT rev (3m)-1.86%
EPS NQ rev (1m)0.3%
EPS NQ rev (3m)32.16%
EPS NY rev (1m)0%
EPS NY rev (3m)26.79%
Revenue NQ rev (1m)-0.07%
Revenue NQ rev (3m)4.05%
Revenue NY rev (1m)0.09%
Revenue NY rev (3m)1.56%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.61 | ||
| Fwd PE | 18.15 | ||
| P/S | 1.24 | ||
| P/FCF | 15.99 | ||
| P/OCF | 9.65 | ||
| P/B | 1.13 | ||
| P/tB | 4.89 | ||
| EV/EBITDA | 12.56 |
EPS(TTM)1.87
EY6.02%
EPS(NY)1.71
Fwd EY5.51%
FCF(TTM)1.94
FCFY6.25%
OCF(TTM)3.22
OCFY10.36%
SpS25.03
BVpS27.51
TBVpS6.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.08% | ||
| ROE | 1.83% | ||
| ROCE | 1.13% | ||
| ROIC | 0.89% | ||
| ROICexc | 1.22% | ||
| ROICexgc | 8.95% | ||
| OM | 1.52% | ||
| PM (TTM) | 2.01% | ||
| GM | 43.88% | ||
| FCFM | 7.76% |
ROA(3y)-0.02%
ROA(5y)1.07%
ROE(3y)-0.07%
ROE(5y)1.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-30.61%
ROICexc growth 3Y-63.57%
ROICexc growth 5Y-44.11%
OM growth 3Y-60.62%
OM growth 5Y-43.72%
PM growth 3Y-45.27%
PM growth 5Y-30.27%
GM growth 3Y-4.46%
GM growth 5Y-2.57%
F-Score7
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 3.83 | ||
| Debt/EBITDA | 1.59 | ||
| Cap/Depr | 67.12% | ||
| Cap/Sales | 5.09% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 141.11% | ||
| Profit Quality | 386.27% | ||
| Current Ratio | 1.42 | ||
| Quick Ratio | 1.24 | ||
| Altman-Z | 1.92 |
F-Score7
WACC6.73%
ROIC/WACC0.13
Cap/Depr(3y)62.08%
Cap/Depr(5y)71.19%
Cap/Sales(3y)4.74%
Cap/Sales(5y)5.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.5%
EPS 3Y-23.52%
EPS 5Y-9.56%
EPS Q2Q%-11.76%
EPS Next Y-7%
EPS Next 2Y0.31%
EPS Next 3Y6.56%
EPS Next 5YN/A
Revenue 1Y (TTM)6.39%
Revenue growth 3Y-0.59%
Revenue growth 5Y4.4%
Sales Q2Q%4.98%
Revenue Next Year4.08%
Revenue Next 2Y3.92%
Revenue Next 3Y4.12%
Revenue Next 5Y3.77%
EBIT growth 1Y168.06%
EBIT growth 3Y-60.85%
EBIT growth 5Y-41.24%
EBIT Next Year87.65%
EBIT Next 3Y30.41%
EBIT Next 5YN/A
FCF growth 1Y-30%
FCF growth 3Y-8.04%
FCF growth 5Y10.13%
OCF growth 1Y-21.83%
OCF growth 3Y-6.79%
OCF growth 5Y5.3%